Tag Archives: GE BioPharma
Though It Might Be Delayed, GE’s BioPharma Sale is Set to Close
GE’s stock has been battered during this sell-off, falling much more than the broader market as a whole. Since reaching an intra-day peak of $13.26 on February 12 (roughly one month ago), the stock has fallen 40.8% to its March … Continue reading
Posted in GE, Industrials
Tagged Danaher, GE BioPharma, GE Capital, General Electric
Comments Off on Though It Might Be Delayed, GE’s BioPharma Sale is Set to Close